DE202006006049U1 - Alcohol-free food supplement drink, comprises specified substances known to combat modern diseases, e.g. diabetes and obesity - Google Patents
Alcohol-free food supplement drink, comprises specified substances known to combat modern diseases, e.g. diabetes and obesity Download PDFInfo
- Publication number
- DE202006006049U1 DE202006006049U1 DE202006006049U DE202006006049U DE202006006049U1 DE 202006006049 U1 DE202006006049 U1 DE 202006006049U1 DE 202006006049 U DE202006006049 U DE 202006006049U DE 202006006049 U DE202006006049 U DE 202006006049U DE 202006006049 U1 DE202006006049 U1 DE 202006006049U1
- Authority
- DE
- Germany
- Prior art keywords
- alcohol
- food supplement
- obesity
- diabetes
- free food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000126 substance Substances 0.000 title claims abstract description 8
- 235000015872 dietary supplement Nutrition 0.000 title abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 5
- 201000010099 disease Diseases 0.000 title description 4
- 208000008589 Obesity Diseases 0.000 title description 2
- 206010012601 diabetes mellitus Diseases 0.000 title description 2
- 235000020824 obesity Nutrition 0.000 title description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 5
- 239000011707 mineral Substances 0.000 claims abstract description 5
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960001948 caffeine Drugs 0.000 claims abstract description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000010447 xylitol Nutrition 0.000 claims abstract description 4
- 239000000811 xylitol Substances 0.000 claims abstract description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 4
- 229960002675 xylitol Drugs 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 239000009429 Ginkgo biloba extract Substances 0.000 claims abstract 2
- 229940068052 ginkgo biloba extract Drugs 0.000 claims abstract 2
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims abstract 2
- 235000013373 food additive Nutrition 0.000 claims description 2
- 239000002778 food additive Substances 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 235000019520 non-alcoholic beverage Nutrition 0.000 claims description 2
- 229940045613 taurine 1000 mg Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- RSDQBPGKMDFRHH-MJVIGCOGSA-N (3s,3as,5ar,9bs)-3,5a,9-trimethyl-3a,4,5,7,8,9b-hexahydro-3h-benzo[g][1]benzofuran-2,6-dione Chemical compound O=C([C@]1(C)CC2)CCC(C)=C1[C@@H]1[C@@H]2[C@H](C)C(=O)O1 RSDQBPGKMDFRHH-MJVIGCOGSA-N 0.000 abstract 1
- UYUXSRADSPPKRZ-UHFFFAOYSA-N D-glucuronic acid gamma-lactone Natural products O=CC(O)C1OC(=O)C(O)C1O UYUXSRADSPPKRZ-UHFFFAOYSA-N 0.000 abstract 1
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 abstract 1
- 208000001953 Hypotension Diseases 0.000 abstract 1
- RSDQBPGKMDFRHH-UHFFFAOYSA-N Taurin Natural products C1CC2(C)C(=O)CCC(C)=C2C2C1C(C)C(=O)O2 RSDQBPGKMDFRHH-UHFFFAOYSA-N 0.000 abstract 1
- 230000001539 anorectic effect Effects 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 239000008122 artificial sweetener Substances 0.000 abstract 1
- 235000021311 artificial sweeteners Nutrition 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 229950002441 glucurolactone Drugs 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 6
- 229960003080 taurine Drugs 0.000 description 4
- 230000029142 excretion Effects 0.000 description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 231100000317 environmental toxin Toxicity 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 244000228088 Cola acuminata Species 0.000 description 1
- 235000010205 Cola acuminata Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000015897 energy drink Nutrition 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Alcohol-free food supplement drink comprises per 500 cc of mineral water, the following quantities of substances, expressed in milligrams: taurin 1000, glucuronolactone 600, ginkgo biloba extract 20, caffeine 80. In addition, 10.0 gms of xylitol (artificial sweetener) are included. The protection provided by the composition is a function of the type and quality of substance, including the mineral water. ACTIVITY : Anorectic; Hypotensive; Cardiant; Vasotropic; Antidiabetic. No biological data given. MECHANISM OF ACTION : None given.
Description
- 1. Alkoholfreies Getränk als Lebensmittelzusatz1. Alcohol-free drink as a food additive
- 2. 1. + 2. Die üblichen auf dem Markt befindlichen Getränke enthalten neben Fruchtsäften, Aromen, Vitamine, Zucker, Koffein (z. Teil aus Cola Nuss z. Teil aus Schwarztee) Ziel: wohlschmeckendes anregendes Getränk – Wellness2. 1. + 2. The usual contained in the market drinks in addition to fruit juices, Flavors, vitamins, sugar, caffeine (part of cola nut for part from black tea) Goal: savory stimulating drink - Wellness
- 3. In den letzten Jahren nahmen Zivilisationskrankheiten wie Fettsucht, Hochdruck, Herzkreislauferkrankungen und Diabetes enorm zu. Vor allem erkranken immer jüngere Personen. Gründe: Fehlernährung, Bewegungsmangel, es wird zu wenig getrunken. Neben einer sehr schwierig zu ermittelnden individuellen Diät, mehr Bewegung, mehr Flüssigkeit – ohne Inhaltsstoffe, die weitere Flüssigkeitszufuhr erfordern, können nur Lebensmittelergänzungen mit Stoffen, die den Stoffwechsel anregen, den Elektrolytstoffwechsel fördern, die Ausscheidung von Abbauprodukten und Umweltgiften beschleunigen den genannten Zivilisationsschäden entgegenwirken.3. In recent years, civilization diseases such as Obesity, hypertension, cardiovascular disease and diabetes tremendously to. Above all, younger and younger people are getting sick People. Reasons: malnutrition, lack of exercise, it is not drunk enough. In addition to a very difficult to be determined individual diet, more exercise, more fluids - no ingredients, require further fluid intake, can only food supplements with Substances that stimulate the metabolism, the electrolyte metabolism promote, accelerate the excretion of degradation products and environmental toxins the mentioned civilization damage counteract.
- 4. Es wurde dazu ein Getränk zusammengestellt aus Stoffen, die im Körper gebildet werden, zugleich aber auch üblicher Weise in der Nahrung enthalten sind und entsprechend erforschte in klinischen Prüfungen bestätigte Funktionen ausüben. Diese Stoffe wurden durch pflanzliche Zusätze hier Ginkgo Biloba ergänzt dessen Effekt seit mehreren hundert Jahren im asiatischen Raum bekannt ist, der auch noch jüngst international durch klinische Prüfungen bestätigt wurde: Taurin fördert den Gesamtstoffwechsel und wirkt auch bei hohen sportlichen Belastungen der Übersäuerung entgegen. Es besitzt einen starken insulinähnlichen Effekt und dient aufgrund seiner Eigenschaften als Konjugationsmittel für Umweltgifte wie z.B. Schwermetalle und zu deren Ausscheidung. Taurin bessert den Allgemeinzustand bei Stauungsherz, normalisiert beginnenden Hochdruck fördert den Elektrolytstoffwechsel und ist für Frühgeborene vital. Glukuronsäure wird von der Leber aus Blutglukose gebildet und dient der Ausscheidung aller körpereigenen Hormone, vieler Abbauprodukte, fast aller Arzneistoffe. Beide Stoffe wurden einzeln und gemeinsam mit viel Zucker (bis zu 50,0g/Drink) als „Sportdrink" oder „Energy drink" in vielen Ländern in den Handel gebracht. Xylitol ist der einzige derzeit verfügbare Zuckerersatzstoff der ohne Nebenwirkungen und ohne Insulin in die Zellen aufgenommen wird. Es dient als „Zündfunke" für den Kohlenhydratstoffwechsel bei Glukosemangel. Xylitol wird zu Xylolol abgebaut. Xylolol wiederum ist ein wichtiger Aufbaustoff für die Nukleinsäuren. Koffein stütz den durch Taurin stimulierten Hirnstoffwechsel und erhöht zusätzlich die Vigilanz. Ginkgo Biloba fördert im ganzen Körper die Mikrozirkulation und fördert dadurch wieder den Effekt Taurin auf den Stoffwechsel 500 ccm Mineralwasser ist die unbedingt notwendige Menge Wasser um einen schnellen Effekt der Stoffe zu bewirken.4. It was a drink composed of substances that are formed in the body, at the same time but also more usual Are included in the diet and researched accordingly in clinical trials confirmed Exercise functions. These substances were supplemented by herbal additives here Ginkgo Biloba Effect known for several hundred years in Asia who is also youngest internationally through clinical trials approved has been: Taurine promotes the total metabolism and acts even at high levels of physical stress the hyperacidity against. It has a strong insulin-like Effect and serves as a conjugating agent due to its properties for environmental toxins such as. Heavy metals and their excretion. Taurine is improving the general condition in congestive heart, starting normalized Promotes high pressure the electrolyte metabolism and is vital for premature babies. Glucuronic acid is formed by the liver from blood glucose and is used for excretion all of the body's own Hormones, many breakdown products, almost all drugs. Both Fabrics were taken individually and together with a lot of sugar (up to 50.0g / drink) as a "sports drink" or "energy drink "in many countries put on the market. Xylitol is the only currently available sugar substitute taken in the cells without side effects and without insulin becomes. It serves as a "spark" for the carbohydrate metabolism in the case of glucose deficiency. Xylitol is degraded to xylene. Xylene in turn is an important building material for the nucleic acids. caffeine support the stimulated by taurine brain metabolism and additionally increases the Vigilance. Ginkgo Biloba promotes in the whole body the microcirculation and promotes This again restores the effect of taurine on the metabolism 500 cc of mineral water is the absolutely necessary amount of water for a quick effect to cause the substances.
- 5. Das Getränk kann aufgrund seiner Zusammensetzung beim gesunden Konsumenten eine Erhöhung der Leistungskraft, einen Stressabbau und eine Verlängerung der Leistungsdauer bewirken und bei regelmäßiger Verwendung in Verbindung mit körperlicher Bewegungstherapie eine echte Prophylaxe für die unter 3. genannten Zivilisationserkrankungen sein. Bei Personen, die bereits unter einer der genannten Zivilisationskrankheiten leiden ist eine deutliche Verbesserung des Allgemeinzustandes zu erwarten und eine Prophylaxe gegen periphere Durchblutungs- und Stoffwechselstörungen.5. The drink Due to its composition in the healthy consumer one can increase the power, a stress reduction and an extension the duration of use and, when used regularly in conjunction with physical Movement therapy a real prophylaxis for the mentioned under 3. civilization diseases be. In persons already suffering from one of the civilization diseases mentioned suffering is a significant improvement in the general condition too expect and prophylaxis against peripheral circulation and Metabolic disorders.
- 6. Das Getränk ist so konzipiert, dass es bei allen genannten Zivilisationserkrankungen ohne Einschränkungen oder Therapieänderungen getrunken werden kann. Es ist m. E. kein Getränk im Handel das vergleichbar verwendet werden könnte.6. The drink is designed to be used in all of these civilization disorders without restrictions or therapy changes can be drunk. It is m. E. no drink in the trade that could be used comparably.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE202006006049U DE202006006049U1 (en) | 2006-04-13 | 2006-04-13 | Alcohol-free food supplement drink, comprises specified substances known to combat modern diseases, e.g. diabetes and obesity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE202006006049U DE202006006049U1 (en) | 2006-04-13 | 2006-04-13 | Alcohol-free food supplement drink, comprises specified substances known to combat modern diseases, e.g. diabetes and obesity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE202006006049U1 true DE202006006049U1 (en) | 2006-08-31 |
Family
ID=36999462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE202006006049U Expired - Lifetime DE202006006049U1 (en) | 2006-04-13 | 2006-04-13 | Alcohol-free food supplement drink, comprises specified substances known to combat modern diseases, e.g. diabetes and obesity |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE202006006049U1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3442358B1 (en) * | 2016-04-11 | 2021-02-17 | Société des Produits Nestlé S.A. | Infant nutrition delivering metabolic benefits |
-
2006
- 2006-04-13 DE DE202006006049U patent/DE202006006049U1/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3442358B1 (en) * | 2016-04-11 | 2021-02-17 | Société des Produits Nestlé S.A. | Infant nutrition delivering metabolic benefits |
| AU2017251143B2 (en) * | 2016-04-11 | 2021-05-20 | Société des Produits Nestlé S.A. | Infant nutrition delivering metabolic benefits |
| US11388922B2 (en) | 2016-04-11 | 2022-07-19 | Societe Des Produits Nestle S.A. | Infant nutrition delivering metabolic benefits |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5614224A (en) | Nutritional supplement for diabetics | |
| DE3319575C2 (en) | ||
| WO2018024887A1 (en) | Composition for the treatment of veisalgia | |
| DE202006006049U1 (en) | Alcohol-free food supplement drink, comprises specified substances known to combat modern diseases, e.g. diabetes and obesity | |
| WO2014012190A2 (en) | Method for the improved absorption of isotonic, probiotic beverages by way of electrolysis for splitting the water molecule chains into a micro-cluster formation | |
| CN101601681A (en) | The pharmaceutical composition that is used for blood sugar lowering and blood fat | |
| CN101474304A (en) | Pharmaceutical composition for reducing blood sugar and blood fat | |
| DE10352822A1 (en) | Use of an additionally fermented cereal sludge for the prevention and / or treatment of elevated blood sugar levels | |
| LU501504B1 (en) | POWDERED FOOD SUPPLEMENT FOR MAKING A BEVERAGE | |
| RU2464996C1 (en) | Composition showing restorative, general tonic and antidepressant action | |
| CN101584706A (en) | Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes | |
| AT413069B (en) | Nutritional supplements showing good gastrointestinal tolerance comprise powders or derived drinks containing minerals, vitamins and carbohydrates, including sodium pyrophosphate | |
| CN101474299B (en) | Pharmaceutical composition for reducing blood sugar, blood fat and treating diabetes | |
| CN101584710A (en) | Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes | |
| CN101474339B (en) | Pharmaceutical composition for reducing blood sugar | |
| DE102006001035A1 (en) | Oral administration agent, useful e.g. as food auxiliary and to treat e.g. diabetes, comprises substance, which increase the viscosity of liquid and active agent, that delays, slows down/inhibits the hormonal emptying reflection of stomach | |
| CN101574404A (en) | Drug composition for reducing blood fat | |
| CN101601683A (en) | The pharmaceutical composition that is used for blood sugar lowering and blood fat and treatment diabetes | |
| CN101461868A (en) | Pharmaceutical composition for reducing blood sugar, blood fat and treating diabetes | |
| CN101579372A (en) | Medicine composition for reducing blood fat | |
| CN101569651A (en) | Medicinal composition for lowering blood sugar | |
| CN101601684A (en) | The pharmaceutical composition that is used for blood sugar lowering and blood fat and treatment diabetes | |
| CN101601682A (en) | The pharmaceutical composition that is used for blood sugar lowering and blood fat | |
| CN101474335A (en) | Pharmaceutical composition for reducing blood sugar | |
| CN101596209A (en) | The pharmaceutical composition that is used for blood sugar lowering and blood fat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R207 | Utility model specification |
Effective date: 20061005 |
|
| R156 | Lapse of ip right after 3 years |
Effective date: 20091103 |